Outcomes Researcher and Translation Specialist Barbara Gandek Joins
LINCOLN, R.I., April 24 /PRNewswire/ -- As part of its continuing commitment to international research, QualityMetric today announced that Barbara Gandek, MS has accepted the position of Senior Scientist and Director of International Research & Development. Gandek will report to James E. Dewey, PhD, Chief Innovation & Research Officer and continue to work closely with her colleague of 19 years, John E. Ware Jr., PhD, QualityMetric's founder and CEO.
During her career, Gandek has authored or co-authored more than 40 peer-reviewed articles, many of which fostered the development of health outcomes measurement around the world. Barbara spearheaded the ongoing effort to translate the entire suite of adult SF Health Surveys for use in more than 75 countries and co-edited a special issue of the Journal of Clinical Epidemiology that summarized the work of the International Quality of Life Assessment (IQOLA) Project in the 1990's. She has also been involved in the development of five of the SF manuals, including the most recently published "User's Manual for the SF-36v2 Health Survey - Second Edition."
"QualityMetric is recommitting itself to fostering international outcomes research and to developing additional norms for countries outside the U.S.," says Ware. "No one is better qualified to lead this effort than Barbara."
For years, Gandek worked closely with her colleagues at QualityMetric as a Scientist and Director at the Health Assessment Lab (HAL). Before this, she worked at New England Medical Center's Health Institute, primarily on the IQOLA Project and the Medical Outcomes Study. She holds a Bachelor of Arts degree in Economics from Swarthmore College and a Master of Science in Health Policy & Management from Harvard School of Public Health. Ms. Gandek is an Instructor at Tufts University School of Medicine.
"While at HAL, Barbara was always very supportive of our efforts with the Office of Grants and Scholarly Research," added Dewey. "Having her on the staff full time to direct our international efforts will be a great boost to QualityMetric and to outcomes researchers around the world."
QualityMetric Incorporated works with the world's largest healthcare and life sciences companies to measure health outcomes. Our products help market new drugs and biologics, track health improvement or decline, screen populations for disease, and identify future health risks. QualityMetric's patient-reported outcome (PRO) surveys provide scientifically valid assessments of both physical and mental health. Our PROs include the SF-36v2(R), SF-12v2(R), and SF-8(TM) Health Surveys, SF-10(TM) Health Survey for Children, Asthma Control Test (ACT(TM)), Pain Impact Questionnaire (PIQ-6(TM)), and DYNHA(R) Dynamic Health Assessments. Our Outcomes Insight Consulting(TM) Group can develop customized PROs and provide in-depth analysis of the results. QualityMetric's founder and CEO, John E. Ware Jr., PhD is a thought-leader in the field of psychometrics and health outcome measurement. Visit us at http://www.qualitymetric.com
Copyright©2008 PR Newswire.
All rights reserved